Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ethyl Fumarate
2. Ethyl Fumarate, 2 Copper Salt
3. Ethyl Fumarate, 2 Ferrium Salt
4. Ethyl Fumarate, Calcium Salt
5. Ethyl Fumarate, Lithium Salt
6. Ethyl Fumarate, Maganeese Salt
7. Ethyl Fumarate, Sodium Salt
8. Ethyl Fumarate, Zinc Salt
9. Ethylhydrogenfumarate
10. Fumaric Acid Monoethyl Ester
11. Monoethyl Fumarate
12. Zinc Monoethylfumarate
1. 62008-22-4
2. Fumaric Acid Monoethyl Ester Calcium Salt
3. Calcium;(e)-4-ethoxy-4-oxobut-2-enoate
4. 37sbe2s23q
5. Calcium (e)-4-ethoxy-4-oxobut-2-enoate
6. Monoethyl Fumarate Calcium
7. Nsc-103366
8. Nsc-245297
9. Calcium Diethyl Difumarate
10. Unii-37sbe2s23q
11. Einecs 263-369-9
12. Monoethyl Trans-2-butenedioate Calcium Salt
13. Bis[3-(ethoxycarbonyl)acrylic Acid]calcium Salt
14. Ethyl Fumarate Calcium
15. (2e)-2-butenedioic Acid 1-ethyl Ester Calcium Salt
16. Schembl1904369
17. Schembl1904374
18. Ethyl Hydrogenfumarate-calcium
19. Nsc 103366
20. Nsc 245297
21. Calcium(e)-4-ethoxy-4-oxobut-2-enoate
22. Calcium Monoethylfumarate [who-dd]
23. Bis[(e)-3-(ethoxycarbonyl)propenoic Acid]calcium Salt
24. Q27256700
25. 2-butenedioic Acid (2e)-, 1-ethyl Ester, Calcium Salt (2:1)
| Molecular Weight | 326.31 g/mol |
|---|---|
| Molecular Formula | C12H14CaO8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 326.0314583 g/mol |
| Monoisotopic Mass | 326.0314583 g/mol |
| Topological Polar Surface Area | 133 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 154 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
ABOUT THIS PAGE
A Calcium Monoethyl Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Monoethyl Fumarate, including repackagers and relabelers. The FDA regulates Calcium Monoethyl Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Monoethyl Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Monoethyl Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium Monoethyl Fumarate supplier is an individual or a company that provides Calcium Monoethyl Fumarate active pharmaceutical ingredient (API) or Calcium Monoethyl Fumarate finished formulations upon request. The Calcium Monoethyl Fumarate suppliers may include Calcium Monoethyl Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Monoethyl Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Calcium Monoethyl Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Calcium Monoethyl Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Calcium Monoethyl Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Calcium Monoethyl Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Calcium Monoethyl Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Calcium Monoethyl Fumarate suppliers with NDC on PharmaCompass.
Calcium Monoethyl Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Monoethyl Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Monoethyl Fumarate GMP manufacturer or Calcium Monoethyl Fumarate GMP API supplier for your needs.
A Calcium Monoethyl Fumarate CoA (Certificate of Analysis) is a formal document that attests to Calcium Monoethyl Fumarate's compliance with Calcium Monoethyl Fumarate specifications and serves as a tool for batch-level quality control.
Calcium Monoethyl Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Monoethyl Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Monoethyl Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Monoethyl Fumarate EP), Calcium Monoethyl Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Monoethyl Fumarate USP).
LOOKING FOR A SUPPLIER?
